Document is current
Any future updates will be listed below
-
Authors
Jee, Justin http://orcid.org/0000-0001-9783-0139
Stonestrom, Aaron J. http://orcid.org/0000-0002-0602-1158
Devlin, Sean
Nguyentran, Teresa
Wills, Beatriz
Narendra, Varun
Foote, Michael B.
Lumish, Melissa
Vardhana, Santosha A.
Pastores, Stephen M.
Korde, Neha http://orcid.org/0000-0002-5538-4318
Patel, Dhwani
Horwitz, Steven
Scordo, Michael
Daniyan, Anthony F.
- License Information
-
More Information
Article History
Received: 9 October 2020
Accepted: 1 February 2021
First Online: 1 March 2021
Competing interests
: JJ has a patent licensed by MDSeq Inc. AJS holds shares in Aprea Therapeutics and Editas Medicine and his spouse works for and receives salary support from BluePrint Research Group and in the course of her position consults for multiple pharmaceutical companies. SAV has received honoraria from Agios Pharmaceuticals and Rheos Pharmaceuticals, is an advisor for Immunai and has consulted for ADC Therapeutics. SP has received research funding from the Marcus Foundation and from bioMerieux. NK has received research funding from Amgen and has served on an advisory board for Astra Zeneca. MS has served as a paid consultant for McKinsey & Company, Angiocrine Bioscience, Inc., and Omeros Corporation. He received research funding from Angiocrine Bioscience, Inc. He served on an ad hoc advisory board for Kite – A Gilead Company. SH has received research support from ADC Therapeutics, Aileron, Celgene, Daiichi Sankyo, Forty Seven, Inc., Kyowa Hakko Kirin, Millennium/Takeda, Seattle Genetics, Verastem, Portola Pharmaceuticals, and Trillium Therapeutics and has served as a consultant for ADC Therapeutics, C4 Therapeutics, Janssen, Kura Oncology, Kyowa Hakko Kirin, Myeloid Therapeutics, Seattle Genetics, Takeda, and Trillium Therapeutics. AFD has a patent licensed in part by Caribou Biosciences, Inc.
